RESUMO
Ehlers-Danlos Syndromes are a rare group of inherited connective tissue disorders of defective collagen synthesis. They predominantly involve the skin, joints and vessels. Ocular involvement in the form of blue sclera, microcornea and susceptibility to trauma is a common feature of EDS type VI. A minor ocular trauma in these patients can cause globe rupture. We herein report simple and successful management of a case of traumatic subconjunctival dislocation of lens in a patient of EDS type VI.
Assuntos
Adolescente , Túnica Conjuntiva/cirurgia , Síndrome de Ehlers-Danlos/complicações , Traumatismos Oculares/complicações , Feminino , Humanos , Subluxação do Cristalino/etiologia , Ferimentos não Penetrantes/complicaçõesRESUMO
Silicone oil adherence to silicone IOLs after silicone oil removal is a known complication in pseudophakic patients. Droplet removal is difficult and may require IOL exchange. We describe two cases in which silicone oil droplets were observed early in the postoperative period in PMMA pseudophakic eyes and disappeared during silicone oil-fluid exchange--a phenomenon that has not been reported earlier in human PMMA pseudophakic eyes.
Assuntos
Drenagem , Feminino , Humanos , Injeções , Lentes Intraoculares/efeitos adversos , Masculino , Pessoa de Meia-Idade , Polimetil Metacrilato , Óleos de Silicone/administração & dosagem , Fatores de TempoAssuntos
Doença Aguda , Contagem de Células Sanguíneas , Criança , Pré-Escolar , Exoftalmia/sangue , Humanos , Leucemia Mieloide/sangueRESUMO
PURPOSE: To compare the efficacy and safety profile of Timolol maleate 0.5% versus Timolol gel forming solution (GFS) 0.5% in open angle glaucoma in Indian eyes. METHODS: In a prospective crossover study 52 patients of open angle glaucoma, well controlled intraocular pressure (IOP) on 0.5% timolol maleate solution were switched over to timolol GFS once a day, after a washout period of one month. A diurnal IOP measurement was done after 6 weeks and compared with patients on timolol maleate 0.5% twice a day. In addition, side effects reported or observed were compared. RESULTS: Statistically significant difference was not observed in ocular hypotensive effect of the two treatment. The side-effects in both the treatment groups were similar except for higher incidence of blurring of vision in patients on timolol GFS. The compliance was better with timolol GFS, but was not statistically significant. CONCLUSION: The results of this study suggest that the more convenient 0.5% timolol in gel forming solution can be offered as an equally efficacious and well-tolerated alternative to twice daily 0.5% timolol solution in open angle glaucoma.